Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
202 Cards in this Set
- Front
- Back
hyperparathyroidism treatments
|
Thiazide diuretics should be avoided
because they increase calcium reabsorption. |
|
Loops Mm
|
Increases excretion of water and calcium.
Increases urinary calcium excretion, thus, used to treat hypercalcemia. Interferes with chloride-binding cotransport system by inhibiting the reabsorption of sodium and chloride in the: |
|
Loops alert
|
CLINICAL ALERT
Hyperhydration and Furosemide Electrolyte abnormalities, Hypokalemia |
|
Loop diuretics
Furosemide (Lasix) – Adverse Effects |
ototoxicity ....
Na/K/Cl symport this same symporter is in inner ear Weakness Lethargy Dizziness Leg cramps Vomiting Possibly mental confusion |
|
loops - adverse ... with K
|
Furosemide (Lasix) – Adverse Effects
Excessive potassium loss impairs proper functioning of the: Heart Skeletal muscle Kidneys Orthostatic hypotension is a common reaction because of large fluid losses. |
|
interactions , loops
|
Metformin decreases concentrations of furosemide.
Other oral hypoglycemic drugs: Increased potential for hyperglycemia. Auditory toxicity appears to be increased with coadministration of aminoglycosides or cisplatin: Hearing loss of varying degrees may occur. |
|
warfarin and loops
|
loops displaces warfarrin from bound albumin
free drug = warfarrin |
|
Lithium and salicylates with loops
|
Decreased elimination; thus lithium or salicylate toxicity.
|
|
loops precautions
|
Observe for blood dyscrasias and liver or kidney damage.
Perform frequent serum electrolyte, glucose, creatinine, uric acid, calcium, and BUN determinations during first few months of therapy and periodically thereafter. |
|
Hormonal Therapy
Indicated in postmenopausal females. |
Estrogen (Premarin)
Reduces bone re-absorption resulting from hyperparathyroidism. |
|
estrogen C/I
|
Known or suspected pregnancy
Breast cancer Undiagnosed abnormal genital bleeding Active thrombophlebitis, or thromboembolic disorders History of thrombophlebitis, thrombosis, or thromboembolic disorders associated with previous estrogen use (except when used in treatment of breast malignancy) |
|
estrogen interactions
|
May reduce hypoprothrombinemic effect of anticoagulants.
Coadministration of barbiturates, rifampin, (induce hepatic microsomal enzymes) may reduce estrogen levels. |
|
other estrogen interactions
|
Toxicologic effects of corticosteroids may occur as a result of estrogen-induced inactivation of hepatic cytochrome P-450 enzyme.
|
|
Calcimimetic agents (eg., Cinacalcet)
|
tricks cells into thinking too much calcium around ....
so parthyroid will not respond |
|
chief cell receptors
|
Cinacalcet
Increases the affinity of the calcium-sensing receptor (CaSR) on the surface of the chief cell of the parathyroid gland to extracellular calcium. This leads to an increase in intracelluler calcium, thereby decreasing the secretion pf PTH. In turn, this results in lower serum calcium levels. |
|
flecanide
|
1 c antiarrythmic
|
|
Bisphosonates
|
C-P bond ---instead of C-O
cannot be destroyed by osteoclasts |
|
Bisphosphonates Mm
|
Bisphosphonates are stable pyrophosphate analog that bind to hydroxyapatide in bone and act as potent inhibitors of PTH-mediated osteoclastic bone resorption.
|
|
cortisol is an antagonist of ..
|
insulin ..
different Mm , different recptor |
|
synthetic glucocortocoids
|
fludrocortisone, dexamethasone, betamethasone etc
|
|
Clinical Uses of Glucocorticoid
|
A) Congenital Adrenal Hyperplasia is caused by poor production of cortisol (the most common cause). An infant with this disease initially has similar symptoms to those of acute adrenal insufficiency and should initially be treated similarly (i.e. an i.v. administration of hydrocortisone accompanied by correction of fluid & electrolyte imbalance)
|
|
Clinical Uses of Glucocorticoid
|
B) Cushing Syndrome is a consequence of bilateral adrenal hyperplasia some times caused by an ACTH-secreting pituitary adenoma (Cushing’s disease)
Symptoms include a rounded plethoric face, muscle wasting and trunk obesity. Appearance of purple striae, osteoporosis, poor wound heeling and easily bruising skin. Mental disorders, hypertension and diabetes are other serious disorders associated with Cushing syndrome |
|
cushings tx
|
include surgical removal of ACTH-producing pituitary tumor, irradiation of pituitary tumor, or removal of one or both adrenal glands
Large doses of cortisol (300mg) are required initially, the dose is tapered down. Long term HRP is required if adrenal gland are removed. |
|
CLINICAL USES OF GLUCOCORTOCOIDS
|
C) Aldosteronism (primary): adrenal adenoma, adrenal hyperplasia may all result in excessive aldosterone production leading to hypertension, weakness, tetany, hypokalemia, alkalosis and plasma [Na+]
Excessive production of adrenal corticosteroids like deoxycorticosterone, corticosterone, 18-hydroxycorticosterone all with intrinsic salt retaining activity can also produce this syndrome |
|
Low plasma renin and angiotensin 2
|
is a characteristic of primary unlike secondary aldosteronism
Spironolactone is used both for diagnosis and treatment of aldosteronism |
|
Dexamethasone suppression test
|
use for diagnosing Cushing syndrome and also in the differential diagnosis of psychiatric state.
|
|
Distinguishing between pseudo-Cushing’s syndrome and bona fide Cushing’s syndrome.
|
A combine test of dexamethasone and CRH is required. A small dose of dexamethasone is administered every 6hrs for two days, followed with a standard CRH test.
A plasma cortisol concentration 1.4mg/dl measured 15minutes after cortisol administration distinguished Cushing’s syndrome |
|
Distinguish between Cushing’s disease and steroid-producing tumors of the adrenal gland or an ectopic ACTH syndrome
|
. 0.5mg oral dexamethasone is administered every 6hrs for two days followed by oral 2mg every 6hrs for two days. A 50% in urine cortisol levels distinguishes Cushing’s disease
|
|
Clinical Uses of Glucocorticoids
|
Stimulation of Lung maturation in fetus
Lung maturation is stimulated by fetal cortisol. Prior to premature deliver a maternal dose of an intramuscular betamethasone is administered to avert fetal respiratory distress syndrome |
|
Betamethasone
|
is a better choice than cortisol because of less maternal protein binding and placental metabolism. This makes it more available to the fetus across the placenta
|
|
glucocortocid toxicity
|
Osteoporosis
Impaired wound healing Peptic ulcers, psycosis (with large doses), salt retention and its complications(cortisone, hydrocortisone) Redistribution of fat from periphery to trunk Protein break down |
|
glucocortocoid C/I and cautions
|
should be taken to watch for Hyperglycemia, glycosuria, sodium retention with edema and / or hypertension, hypokalemia, peptic ulcer, osteoporosis and hidden infection
May be contraindicated or use great caution in peptic ulcer, hypertension with heart failure, tuberculosis, psychosis, osteoporosis, or glaucoma |
|
mineralocorticoids
|
Aldosterone, Deoxycorticosterone and Fludrocortisone
|
|
mineralocortocoids , specifics..
|
udrocortisone is a synthetic glucocorticoid and has a reputation as the most commonly prescribe salt-retaining hormone
Deoxycorticosterone has similar pharmacology as aldosterone but less important pharmacologically Aldosterone is the most important mineralocorticoid in humans. It is regulated by at least two pathways: ACTH and the renin-angiotensin pathways. |
|
Physiologic and Pharmacologic Effects
mineralocortocoids |
aldosterone promotes , mechanism
Na+/K+ ATPase |
|
Deoxycorticosterone
|
(DOC) is an endogenous precursor of aldosterone and is normally secreted in far lower amounts than aldosterone.
Unlike aldosterone, the release of DOC is controlled mainly by ACTH |
|
Fludrocortisone
|
is a potent synthetic steroid with both glucocorticoid and mineralocorticoid activity
As low as 0.1mg dose seven times per week are very effective in treating adrenocortical insufficiency associated with mineralocorticoid defficiency |
|
extracellular calcium effect on Na channels
|
high calcium gets in the way, inhibits excitable Na channels
symptoms : cramping and tetany Weakness Mental slugishness Constipation, gastoparesis |
|
hypocalcemia
symptoms |
Na free to tickle receptors
excitability: Spasms: hands/wrists & feet/ankles first, diaphragm last Excitability, aggression, nervousness, etc. Diarrhea & other GI issues |
|
Magnesium in Premature labor
|
Mg2+ is used to delay labor by inhibiting smooth muscle
|
|
Acidosis
|
excitability due to both H+ & K+
|
|
Alkalosis
|
Free Ca2+ may account for high lethality (COD **** )
|
|
Hyperventilation
|
acute respiratory alkalosis, → free Ca++ levels.
numbness & tingling associated with hyperventilation |
|
levy--hypercalcemia S and S
|
Polyuria
Nausea, vomiting, constipation Confusion, coma, death so levy , hypercalemia COD McCabe -hypocalcemia |
|
levy - SS hypocalc
|
tetany , prolonged QT
|
|
PTH
|
preprohormone
less than 2 hours stored amount calcium levels regulate degredation |
|
actions of PTH
|
Increases bone resorption of Ca++
Increases renal reabsorption of Ca++ Increases intestinal absorption of Ca++ (via Vitamin D3) PTH prevents hypocalcemia due to dietary insufficiency by release of Ca++ from bone (largest supply) |
|
actions of PTH part II
|
PTH increases both Ca++ & phosphate release from bone
PTH increases renal phosphate clearance . . . prevents the formation of calcium-phosphate precipitates |
|
biochem -mechanics of PTH ****
|
binds to receptors in kidney & bone
Receptor linked to two G-proteins: Gs + Gq- activate protein kinases |
|
regulation of PTH secretion
|
Low plasma levels of Ca++ stimulate PTH secretion via . . .
G-protein - Ca++ receptor on the parathyroid membrane senses low Ca++ The G-protein adenyl cyclase & ↑ cAMP production release of PTH |
|
clearance of PTH
|
T½ 2-4 minutes
parathyroidectomy complication |
|
D2 (ergocalciferol-diet)
+ D3 (cholecalciferol- skin) |
gives u Vitamin D )not really a vitamin but a sterol hormone
|
|
synthesis of vitamin D
|
requires sunlight to convert 7-dehydrocholesterol to vitamin D3- nonenzymatic
2 hydroxylations occur- 1st in liver, 2nd in kidneys |
|
liver rxn LO 6
|
1st hydroxylation- 25-hydroxylase converts vitamin D3 to 25(OH)D3.
|
|
kidney rxn LO6
|
2nd hydroxylation, **1-alpha-hydoxylase , to form 1,25-(OH)2D3
|
|
Vitamin D-binding protein
|
Transports Vitamin D3 to the liver
Transports 25(OH)D3 to the kidney |
|
Regulation of Vit D Metabolism & Synthesis
|
1a-hydoxylase- the key to Vit D synthesis
Regulators of 1a-hydroxylase PTH (stimulates) 1,25(OH)2D3 (inhibits) Glucocorticoids (inhibits) |
|
pathophys of hypercalcemia and hypercalciuria
|
thought to be due to an increased conversion of
1-OH vitamin D3 to the active 1,25(OH)2 vitamin D3 by macrophages and epithelioid cells from granulomas. |
|
Mode of Action of Vitamin D3
|
Typical steroid hormone
Intracellular receptor (like steroids, thyroid hormone) Hormone-receptor complex (HRC) binds to DNA- hormone response element (promoter region) The HRC modulates transcription- RNA polymerase II |
|
genetic affect of the steroid hormone vitamin D
|
Induces transcription of Ca++ binding protein, ***calbindin, in the brush border
Intestine primary target of vitamin D Increases Ca++ absorption |
|
actions of vitamin D -- LO 4 *******
|
Constant remodeling
Primary target cell- osteoblast, Vit D builds strong bones by stimulating transcription, producing ****osteocalcin, collagen type I, and alkaline phosphatase. Indirectly stimulates osteoclast- increases release of Ca++ & PO4 into blood so affects both |
|
other issues with Vitamin D
|
Maturation of hair follicles (lack of vit D receptors- life long alopecia totalis)
Inhibits epidermal kerotinocytes- treatment of psoriasis |
|
nutrition of vit D
|
D2- milk and dairy
D3 - fish and eggs |
|
symptoms of hypercalcemia levy II
|
Nausea, vomiting, constipation
Polyuria, polydipsia nephrogenic DI Malaise, weakness Myopathy |
|
signs of hypercalcemia
objective |
Hypertension
Nephrolithiasis MS changes- memory loss, confusion Hyporeflexia Coma Short QT interval**** |
|
Causes of Hypercalcemia****
|
Multiple Myeloma
Bony mets Sarcoidosis Thiazides Vitamin A and D intoxication Adrenal insufficiency Pheo |
|
hyperparathyroidism
|
Usually adenoma (primary hyper PTH)
Asymptomatic Hypercalcemia inc PTH dec PO4 |
|
hyperpara in renal disease ?
distinguishing factor |
PO4 will be high ****
PTH up ***** |
|
surgery is indicated for hyperparathyroid when ?
|
Renal insuff
***Kidney stones- recurrent **Bone disease (osteitis fibrosa cystica) Watch for post op ??? |
|
causes of hypocalcemia
|
Acute pancreatitis
Hyperventilation Post op PTH CRF Hypomagnesemia Blood tx |
|
hypo
|
alkylo
|
|
rickets
|
Rickets occurs when vitamin D production and intake are, together, inadequate for needs. Levels were very high at one time but fell greatly after milk was supplemented with vitamin D. There has been a resurgence with less outdoor activity and less milk consumption in children.
Rickets is characterized by hypocalcemia bones and periodic carpal or pedal tetany. Increased bone flexibility with slow mineralization causes the bones to bend under the weight of the body. |
|
osteomalacia (soft bones)
|
Osteomalacia is a deficiency of vitamin D in mid-late teens or adults.
Causes include: Steatorrhea, sometimes with symptoms of vitamin A (night blindness), E or K (bleeding) deficiency (treat with vitamin D) Liver failure (treat with 25-OH vitamin D) Renal disease (treat with 1, 25-OH vitamin D – far more difficult to manage) |
|
osteoporosis primary cause
|
Primary cause is likely reduced bone stress due to reduced exercise in modern society.
|
|
Pagets
|
Paget’s disease is an inappropriate activation of osteoclasts followed by activation of osteoblasts so bone turnover is greatly increased.
|
|
Radiologic and Ultrasound Quantification of Bone Loss
DEXA |
(dual energy X-ray absorptiometry): standard for measuring hip & spine BMD (2 major fracture sites)
- Used for osteoporosis diagnosis and monitoring |
|
SXA
|
Single energy x-ray absorptiometry (SXA): measure peripheral sites (wrist, heel)
- Do not use for diagnosis and management |
|
OsteoporosisMedication Risk Factors
|
prednisone **
Thyroid supplements Chronic lithium therapy Heparin Chemotherapy Methotrexate Anticonvulsants (ex: phenytoin, phenobarbital) Drugs alter Ca absorption: tetracycline, Al antacids Drugs alter Ca elimination: loop diuretics Immunosuppressants Parental nutrition Medroxyprogesterone acetate (black box warning on insert) Cyclosporine Tacrolimus |
|
diet
|
most adults need 800 to 1000mg of Ca daily
* 400IU of vitamin D daily |
|
calcium goal
|
1200 mg of calcium / day
|
|
***drug interactions with Calcium supplements
|
Tetracyclines and quinolones (Ca decreases absorption of these drugs)
|
|
Adverse effects of Ca2+ supplements
|
Abdominal cramps, bloating, flatulence an diarrhea
* Caffeine calcium excretion * Hypercalcemia and urinary stones |
|
Bisphosphnates
Mm ? |
inhibit osteoclast activity
reduce resorption and formation of hydroxypatite crystals * inhibit osteoclast activity * long half lives * poor GI absorption |
|
uses
Alandronate, & Risedronate |
prevention & treatement of postmenuposal and glucocorticoid-induced osteoporosis
|
|
Ibandronate
|
treatment and prevention of postmenuposasl osteoporosis
|
|
bisphosphonates adverse****
|
caution in pregnancy
* esophageal ulcer, esophageal stricture, dyspepsia, dysphagia, acid regurgitation, abdominal pain, nausea, diarrhea musculoskeletal pain * osteomalacia ( more with long term therapy of etidronate) |
|
bisphosphonates adverse**** recall
|
bone pain in patients with Pagets
osteomalacia N/D esophagitis . |
|
bisphosphonates C/I
|
hypocalcaemia (other bone & mineral metabolism disturbances)
* severe renal impairment esophageal abnormalities * precaution with gastric ulcers * precaution with dysphagia, esophagitis |
|
calcintonin also used for osteoporosis
adverse ? |
rhitinitis, nasal irritation, nasal dryness
* pain, arthralgia * headache |
|
estrogen and HRT
|
-- stabilizes bone remodeling - stim osteoblasts
promotes calcintonin syn inc vit D recptors .. dec LDL INc HDL relieves hot flashes |
|
Teriparatide
|
Biologically active human PTH
* Stimulates new bone formation * uses: postmenopausal osteoporosis |
|
definitions
|
Osteoporosis: Reduced bone mass- matrix (collagen and mineral)
BMD > 2.5 SD below mean |
|
def
|
Osteopenia: less severe osteoporosis
BMD 1-2.5 SD below mean |
|
def
|
Osteomalacia: abnormal bone mineralization (rickets in kids)
|
|
blue sclera
|
Osteogenesis imperfecta: abnormal collagen
|
|
normal distribution
|
mean, median , and mode are all the same number **
|
|
BMD standard dev - osteoporosis
|
outside of 2.5 SD below the mean
|
|
osteopenia stats
|
BMD 1-2.5 SD below mean
|
|
normal sodium 135-145
|
stat defined , 2 standard dev above and below the mean ********
but 2.5 % outside of range ---can still be normal dont be bent out of shape over every lab abnormality - some normal people .. outside range |
|
exception for SD
cardiology.... |
cholesterol
normal range , but unhealthy ** |
|
secondary osteoporosis
|
hypercortisolism
thyrotoxicosis .. immobilization space travel long term heparin (should bbe a short term heparin ) why would u put someone on long term heparin ---- preggers (b/c not warfarin) |
|
bone mineral density test
|
DEXA
|
|
diagnosis
T scores |
T score (not aged matched)
> 2.5 this person has this standard deviation normal girls in front -- T scores will be zero 60 years later -- their T scores dont worry about Z scores |
|
Z score ?
|
also a standard deviation
and it's the standard eviation of an age matched population |
|
you want ...
|
non-aged matched dependant
|
|
Mm of calcitonin
|
inhibits osteoclasts
|
|
Estrogen- a double edged sword
|
Conserves bone mass
Protects against fractures Effective for menopausal symptoms |
|
estrogen - side effect ********
|
Higher incidence of MI, CVA, PTE, and breast CA
JAMA, July 17, 2002, vol. 288, no. 3, pp321-333 |
|
rule for estrogen ...
give what with it ? |
progesteone
Estrogen –builds up the uterine lining … Causes cell growth and cell division Builds up uterus for a preggers Cell growth … can develop uterine cancer… How to minimize.. Combo ---- progesterone –causes shedding of that lining |
|
if had a historectomy
|
can give unopposed estrogen
|
|
Bisphosphonates
|
All anti-resorptive – inhibit osteoclasts *********
dosed weekly or monthly .. after fosamax |
|
Bisphosphonates
common side effect... so how to take ? |
dont go back in lye down
take in the morning with water.. impt instructions *** early in the morning, empty stomach, dont lye down Common side effect Gastritis/esophagitis |
|
SERMS
|
do different things at liver receptors***
Agonist at bone inc BMD Agonist at liver dec LDL cholesterol Inert at uterus Antagonist at breast*** |
|
Calcitonin
|
Inhibits osteoclasts
Nasal spray Modestly effective not a first line agent |
|
no longer used...
|
fluoride.... inc bone mineral density ..
what are we really trying to do ? inc bone mineral dens ? no, just .. keep them from breaking bone |
|
physiological vs clinical end point ****
|
flouride works well in inc bone density.. but , kept breaking bones *******
corticol vs trabelcular bone .. can inc both.... fluoride inc trabeccular part of the bone ... ** have to inc density the right way ********** you think a drug is gooing to be good , b/c good science behind it.. but it has to change clinical end ppoints... will it reduce fracture rates....... |
|
**blood supply to adrenals **
|
1. superior suprarenal artery that comes off of phrenic artery (332 netter)
2. right middle suprarenal artery - off of aorta 3. inferior suprarenal artery (from renal artery) |
|
innervation of adrenals
|
**Sympathetic fibers directly innervate the cells of medulla
Equivalent to postsynaptic neurons |
|
central adrenomedulllary vein is special
|
as it has tunica media containing smooth muscle
|
|
layers of the cortex
|
Zona glomerulosa – globular clusters, small pyramidal cells, rich capillary network
Zona fasciculata – straight cords of large and polyhedral cells - glucocorticoids Zona Reticularis – small cells in anastomosing cords: glucocorticoids and androgens |
|
glomereulosa layer
|
thin , in globule clusters
rich in capillary network MINERALCORTOCOIDS Each cluster is associated with a capillary Cells have abundant SER Secrete mineralocorticoids (aldosterone) Activated by angiotensin II ***Conn’ syndrome: Hypertension Hypokalaemia Metabolic alkalosis |
|
Zona fasciculata
|
cells are arranged in fasciles (cords and bundles)
straight cords , GLUCOCORTOCOIDS Relatively large, lightly staining cells Each cluster is associated with a capillary Cells have abundant SER, Golgi, mitochondria with tubular cristae and many lipid droplets Secrete glucocorticoids (cortisol) and corticosterone Activated by hypothalamus and hypophysis |
|
Zona Reticularis
|
means network
glucocorticoids and androgens Cells are large (but smaller than those of the ZF), tightly packed and stain darkly Each cluster is associated with a capillary Cells have abundant SER and many lipid droplets |
|
Cushings syndrome vs. cushings disease ...
|
syndrome : central obesity
|
|
addison's disease
|
Hypotension
Hyperkalemia Hair loss in women Vs Addisons (ACTH↓) |
|
what's in the adrenal medulla ?
|
chromafinn cells
vessicles with norepi and epi chrome salt staining : cells with NorEpi are oxidized to a darker color **** norepi is also found in larger vessicles |
|
adrenal medulla ganglion cells are contacted by preganglionic sympathetic fibers
|
are contacted by preganglionic sympathetic fibers
|
|
blood supply to the medulla of adrenal
|
The medulla has a dual blood supply:
Arterial blood from the medullary arterioles Venous blood for the cortical sinusoids |
|
hydroxyl at the 17 position =
|
glucocortocoid
|
|
biochem of zona glomerulosa
|
makes aldosterone
***lacks cytoc P450 (17-alpha hydroxylase) and cant make cortisol or androgens |
|
Zona fasciculata and zona reticularis
function, biochem |
***lacks the 18
function as a unit produce cortisol and androgens lack the enzyme cytochrome P450C18 (18β-hydroxylase) and thus cannot produce aldosterone |
|
steroids in adrenal gland
from cholestrol and LDL stimulation ? |
results in:
hydrolysis of stored cholesterol esters to free cholesterol increased uptake of cholesterol from plasma lipoproteins synthesis of cholesterol within the adrenal cells |
|
cum path question
|
Follicular adenoma goes outside of capsule ….. And causes carcinoma
|
|
Osteitis fibrosa cystica*********
|
Cortex is grossly thinned
Marrow has increased amounts of fibrous tissue Foci of hemorrhage and cyst formation Brown tumors Aggregates of osteoclasts, reactive giant cells, and hemorrhagic debris |
|
Painful bones, renal stones, abdominal groans, and psychic moans
|
Primary hyperparathyroidism
|
|
Calciphylaxis
|
Vascular calcification associated with secondary hyperparathyroidism
Significant ischemic damage to skin and other organs |
|
DiGeorge syndrome
|
Thymic defects + absence of parathyroid glands
|
|
tetany
|
low plasma calcium
|
|
Pseudohypoparathyroidism
|
End-organ resistance to actions of PTH
Serum PTH levels are normal or elevated PTH resistance Most obvious clinical manifestation Hypocalcemia Hyperphosphatemia Elevated circulating PTH |
|
cushing disease ***
vs syndrome |
in the pitutitary is cushing disease *******
ACTH-secreting pituitary microadenomas |
|
small cell tumors secrete ?
|
ectopic ACTH
|
|
Waterhouse-Friderichsen Syndrome
|
Overwhelming bacterial infection (Neisseria meningitidis septicemia)
Rapidly progressive hypotension leading to shock DIC associated with widespread purpura Rapidly developing adrenocortical insufficiency Massive bilateral adrenal hemorrhage |
|
Li-Fraumeni syndrome
|
Germline p53 mutations
|
|
rule of 10s
|
10% of pheochromocytomas are extra-adrenal
10% of sporadic adrenal pheochromocytomas are bilateral 10% of adrenal pheochromocytomas are biologically malignant 10% of adrenal pheochromocytomas are not associated with hypertension |
|
cholestrerol to pregenolone
|
Desmolase
|
|
pregnelone to 17 alpha-OH preg
|
17 alpha-hydroxylase
can make cortisol if def in |
|
17
|
no androgens
|
|
18
|
takes you to aldosterone
|
|
symptoms for cushings
|
central obesity
facial plethora depression/anxiety abdominal striae dorsal fat pad hypertension glucose intolerance hirsutism Acne***** amenorrhea |
|
Aminoglutethamide
|
inhibits conversion of cholesterol to pregnenolone)
cushings tx |
|
key with aldosterone as far as ddx
|
under the control of two systems
under the control of 18 two loops for an 8 (two pathways ) |
|
types of steroids
|
catabolic - cortisol****
(some are anabolic-- such as androgens ) |
|
cushings syndrome vs cushingsdisease..again !!!
|
cushings diseaseis from a pituitary adenoma
cushings syndrome -- from an adrenal adenoma, exogenous steroids oat celllung CA adrenal cancer |
|
ACTH dependency...
|
an adrenal adenoma that secretes cortisol is ACTH independent
pituitart adenoma, oat cell, are ACTH dependent |
|
treatment for cushings
|
dexamethasone ?
|
|
dx cushings..
|
24 hour urine collection -- will see free cortisol
do a CT , brain, belly, chest |
|
Overnight dexamethasone suppression test (DST-screening test)
|
normally if you give someone a steroid , you will stop making cortisol .. neg feedback type
low dose doesn't work , but high dose does ? the problem is at the pituitary |
|
dx of cuhsings...more
|
can also look at ACTH
if high ... then at pituitary if low, then at adrenal can also sample inferior petrosal sinus ****sure sign me up |
|
more on cushings tx ***********
|
Aminoglutethamide (inhibits conversion of cholesterol to pregnenolone)
|
|
I have hyperaldosteronism , but normal cortisol production
|
cortisol not made in glomerula
|
|
embryology of adrenal medulla
|
neural crest migrate
medulla-more like nervous tissue then endocrine because.. the chomaffin cells receive pre-synaptic inneration**** |
|
what is made in adrenal medulla ?
|
mostly epi
norepi made in brain (locus cerrulus ?) |
|
COMT enzymne
|
catecol-O-methyl transferase-
breaks down norepi into normatenephrine this is inhibited by Entacapone, used to treat parkinsons... backs up whole system .. |
|
tumors in adrenal medulla
|
Pheo
DDx: hyperthyroidism, anxiety, cocaine abuse, hypoglycemia |
|
super-important
tx of Pheos ************* (order) |
alpha blockers then beta blockers..
if u give beta blockers first .. then alpha actions are unopposed in vessel... already htn , will clmap down even more!!!!!!!!!1 |
|
Incidental-oma "
|
over 5 cm a problem
|
|
adrenal insuff
types... |
primary -- addison's --auto-antibodies..
will see lymphocitic infiltrate secondary= pituitary problem |
|
addison has ?
|
lacks gfr ?
hypotnesion , hyponatremia , hypeerkalemia , hypoglycemia hyperpigmentation ACTH would be up , so hyperpigmentation *********** |
|
patient on steroids
|
Normally ACTH inject, cortisol should go up
In primary adrenal failure= no response Wont have inc in cortisol like supposed to Flud– synthetic mineralocortociod ****** take exogenous steroids---- will atrophy .. Adrenals -- will suppress adrenals… Wont respond to stress *** Have to give more steroids.. Not being on, but having been on.. Asthma- I get stoids… Wont respond to stress if you have been on steroids – this effect can last a year *************************** Have to give them steroids------------ to get them through …. How long do you have to be on for, for this to happen ? One week ******have to give steroids… in order to make cortisol …. |
|
ACTH
|
ACTH is synthesized in the anterior pituitary.
ACTH secretion is stimulated by CRH and inhibited by cortisol ACTH stimulates the secretion of adrenocortical steroids from the adrenal cortex |
|
details of ACTH and cortisol syn
|
G protein mediated
ACTH stimulates cholesterol release by a lipase and transport across the mitochondrial membrane by StAR (steroidogenic acute response protein) |
|
steps in syn of cortisol
|
CYP450scc
3β-hydroxysteroid dehydrogenase CYP17A CYP21A CYP11 4 of 5 are cytochromes |
|
***reductive biosynthesis
|
Hydroxylation reactions in steroid biosynthesis are catalyzed by Cytochrome P450-containing enzymes
Cytochrome P-450 enzymes are required for the hydroxylation of steroids to yield adrenocortical hormones. |
|
vitamins involved with reductive biosynthesis
|
B2 and B3
riboflavin and niacin |
|
cytochromes in steroid metabolism
|
CYP2, 11,17,19,21
|
|
going from tyrosine to dopamine there is an intermediate .. to get ot this intermediate there is a cofactor....
|
tetrahydrobioterin
|
|
blood supply to anterior pituitary
|
Anterior pituitary receives no direct arterial blood supply!
|
|
anterior pituitary embryo
|
rathke's poutch
|
|
Gonadotropes (FSH and LH cells) – Basophils
|
10% of the anterior lobe
Small cells, eccentric round nuclei, basophilic and PAS stain Most of the cells produce both FSH and LH FSH and LH release is regulated by hypothalamic gonadotropin-releasing hormone, GnRH (=luteinizing hormone-releasing hormone, LHRH) |
|
Thyrotropes (TSH cells) – Basophils
|
5% of the anterior lobe
Large cells, eccentric round nuclei, basophilic and PAS stain TSH release is regulated by hypothalamic thyrotropic-releasing hormone (TRH) |
|
Somatotropes (GH cells) – Acidophils
|
***50% of the anterior lobe
Medium sized cells, central round nuclei, eosinophilic granules GH release is regulated by hypothalamic GHRH and somatostatin Overproduction of GH results in gigantism and acromegaly |
|
Lactotropes (PRL cells, mammotrophes) – Acidophils, Chromophobes
|
15-20 % of the anterior lobe
Large cells, oval nuclei, eosinophilic granules (granules released -> chromophobes) PRL release is regulated by hypothalamic TRH, VIP(stim.) and dopamine (inh.) During pregnancy and lactation these cells undergo hypertrophy -> larger pituitary |
|
Corticotropes (ACTH cells) – Basophils
|
15-20 % of the anterior lobe
Medium sized cells, eccentric round nuclei, basophilic and PAS stain Regulated by hypothalamic corticotropin-releasing hormone (CRH) Produce proopiomelanocortin (POMC) that is cleaved into ACTH β-lipotrophic hormone (β-LPH) Melanocyte stimulating hormone (MSH) Endogenous opiates (β-endorphin, enkephalin) |
|
posterior lobe
|
an extendion of the brain
|
|
post pituitary hormones
signaling oxytocin |
G protein , Calcium , PIP2
|
|
vasopressin signaling
V1 or V3 |
calcium , diacyl glycerol
v2-- uses dofferent path********* adenylate cyclase... |
|
oxytocin Mm
|
protein kinase C -- calcium release
calmodulin rleated labor, lactation, digestion calcium binding to calmodulin is issue with calcium related systems |
|
V2 receptors and oxytocin ..
|
Increases water resorption in the kidney by increasing the water permeability of aquaporin-2 water channels in renal luminal membranes
|
|
dopamine and somatostatin
unique b/c ? |
are inhibitory in hypothalmus
somato --- dec growth hormone |
|
IGF-1 stim
|
stimulates proliferation of chondrocytes (cartilage cells), resulting in bone growth
IGF-I also appears to be the key player in muscle growth stimulating differentiation and proliferation of myoblasts |
|
GH effects
|
breakdown of fats
|
|
conivaptam
|
SIADH tx
caldwell |
|
3 sites of action where TSH works
|
1. uptake of iodine into thyroid
2. oganified TG is endocytosed 3. hydrolysis |
|
where is ACTH derived
|
from POMC cells
proopiomelanocortin |
|
action of ACTH
|
stimulates the secretion of adrenocortical steroids from the adrenal cortex
|
|
effects of LH
|
men-stim testosterone production from leydig cells
women- stim estrogen and prgesterone from ovary surge of LH is responsible for ovulation |
|
FSH
|
men - stim testicular growth and angrogen binding to sertoli cells
women - development of ovarian follicle |
|
FSH
|
makes follicles !
frustose -- spermatogeniss |
|
Levi-Lorain Syndrome
|
inability to form IGF 1.
|
|
Giantism
|
excessive juvenile GH secretion, either form the pituitary or a GH secreting tumor. For giantism to occur the epiphysial plates of bones ****must not have closed.
Giants have hyperglycemia which ultimately results in diabetes. |
|
bone plates in acromegaly
|
closed and bones become thicker
|
|
post pituitary nerve endings ?
|
SO and PV nuclei
|